DK602783A - Farmaceutisk praeparat indeholdende calcitonin - Google Patents

Farmaceutisk praeparat indeholdende calcitonin Download PDF

Info

Publication number
DK602783A
DK602783A DK602783A DK602783A DK602783A DK 602783 A DK602783 A DK 602783A DK 602783 A DK602783 A DK 602783A DK 602783 A DK602783 A DK 602783A DK 602783 A DK602783 A DK 602783A
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparation
preparation containing
containing calcitonin
calcitonin
aqueous
Prior art date
Application number
DK602783A
Other languages
Danish (da)
English (en)
Other versions
DK602783D0 (da
Inventor
Daniel Mufson
Musetta A Hanson
Original Assignee
Armour Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Armour Pharma filed Critical Armour Pharma
Publication of DK602783D0 publication Critical patent/DK602783D0/da
Publication of DK602783A publication Critical patent/DK602783A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Otolaryngology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK602783A 1982-12-29 1983-12-28 Farmaceutisk praeparat indeholdende calcitonin DK602783A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45412882A 1982-12-29 1982-12-29

Publications (2)

Publication Number Publication Date
DK602783D0 DK602783D0 (da) 1983-12-28
DK602783A true DK602783A (da) 1984-06-30

Family

ID=23803421

Family Applications (1)

Application Number Title Priority Date Filing Date
DK602783A DK602783A (da) 1982-12-29 1983-12-28 Farmaceutisk praeparat indeholdende calcitonin

Country Status (13)

Country Link
EP (1) EP0115627B1 (fr)
JP (1) JPS59130820A (fr)
AT (1) ATE26215T1 (fr)
AU (1) AU572815B2 (fr)
CA (1) CA1222948A (fr)
DE (1) DE3370586D1 (fr)
DK (1) DK602783A (fr)
IE (1) IE56441B1 (fr)
IL (1) IL70489A0 (fr)
MX (1) MX7547E (fr)
NZ (1) NZ206728A (fr)
PH (1) PH20444A (fr)
ZA (1) ZA839655B (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5989619A (ja) * 1982-10-05 1984-05-23 サンド・アクチエンゲゼルシヤフト カルシトニン組成物およびその用途
CH657779A5 (de) * 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
JPS61194034A (ja) * 1985-02-25 1986-08-28 Teijin Ltd 経鼻投与用粉末状組成物
JPH0651637B2 (ja) * 1985-03-28 1994-07-06 エーザイ株式会社 ペプタイドの吸着防止組成物
GB2177914B (en) * 1985-06-04 1989-10-25 Chugai Pharmaceutical Co Ltd A pharmaceutical composition containing human erythropoietin and a surface active agent for nasal administration for the treatment of anemia
US4692441A (en) * 1985-08-16 1987-09-08 Merck & Co., Inc. Chorine esters as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal cavities
US4731360A (en) * 1985-08-16 1988-03-15 Merck & Co., Inc. Acylcarnitines as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal compartments
DE3601923A1 (de) * 1986-01-23 1987-07-30 Behringwerke Ag Nasal applizierbares arzneimittel, verfahren zu seiner herstellung und seine verwendung
CA1291036C (fr) * 1986-04-23 1991-10-22 Edwin I. Stoltz Administration de medicaments par voie nasale
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
JPH01501708A (ja) * 1987-01-08 1989-06-15 ナステツク　フアーマスーテイカル　カンパニー，インコーポレイテツド アミノ酸の経鼻投与
HU203204B (en) * 1987-09-15 1991-06-28 Sandoz Ag Process for producing suppository containing calcitonin and taurocholic acid
EP0327756B1 (fr) * 1987-11-13 1994-01-26 Smithkline Beecham Farmaceutici S.p.A. Compositions pharmaceutiques contenant une calcitonine et un glycyrrhizinate comme promoteur d'absoption
HU206367B (en) * 1988-04-30 1992-10-28 Sandoz Ag Process for producing acid addition salts of steroid carboxylic acid-amidated taurine and glycine, as well as pharmaceutical compositions comprising such salts
GR880100604A (el) * 1988-09-14 1994-03-31 Sandoz Ag Βελτιώσεις σε ή σχετικά με καλσιτονίνες.
US5514365A (en) * 1988-10-11 1996-05-07 Schiapparelli Salute S.P.A. Pharmaceutical compositions comprising calcitonin for intranasal administration
US5182258A (en) * 1989-03-20 1993-01-26 Orbon Corporation Systemic delivery of polypeptides through the eye
IT8920486A0 (it) * 1989-05-12 1989-05-12 Isf Spa Composizioni farmaceutiche.
JP2514249B2 (ja) * 1989-05-23 1996-07-10 帝人株式会社 安定化されたカルシトニン類医薬組成物
JP2911496B2 (ja) * 1989-09-11 1999-06-23 帝國製薬株式会社 生理活性ポリペプチド含有高吸収性経膣剤
JPH0643339B2 (ja) * 1990-05-25 1994-06-08 旭化成工業株式会社 カルシトニン類水溶液組成物の安定化法
JPH078806B2 (ja) * 1990-08-16 1995-02-01 旭化成工業株式会社 カルシトニン類含有経鼻投与用乳剤
IT1242019B (it) * 1990-11-20 1994-02-02 Ripari Gero Ist Farm Biolog Composizioni farmaceutiche acquose a base di calcitonina, da somministrarsi per via nasale.
DE4222647A1 (de) * 1991-07-15 1993-01-21 Sandoz Ag Peptid-zubereitungen
JPH06305952A (ja) * 1993-04-27 1994-11-01 Sumitomo Pharmaceut Co Ltd スレオ−３−（３，４−ジヒドロキシフェニル）セリン経鼻投与製剤
US5744155A (en) * 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery
US5514670A (en) * 1993-08-13 1996-05-07 Pharmos Corporation Submicron emulsions for delivery of peptides
JPH11292787A (ja) * 1995-08-15 1999-10-26 Asahi Chem Ind Co Ltd 生理活性ペプチドを含有する経粘膜投与製剤
IT1282374B1 (it) * 1996-01-31 1998-03-20 Therapicon Srl Composizioni farmaceutiche parenterali a base di calcitonine sintetiche a ph controllato con basso indice di dolorosita'
CA2288968A1 (fr) 1997-04-14 1998-10-22 Takashi Yazaki Preparation absorbable par les muqueuses
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
JP2000247911A (ja) 1999-02-26 2000-09-12 Hisamitsu Pharmaceut Co Inc 大腸用吸収促進剤
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
WO2001056594A1 (fr) 2000-02-04 2001-08-09 Unigene Laboratories, Inc. Formulations de calcitonine pour administration par voie nasale
JP4493594B2 (ja) 2003-03-04 2010-06-30 田辺三菱製薬株式会社 粉末経鼻投与製剤
WO2004084859A2 (fr) * 2003-03-21 2004-10-07 Nastech Pharmaceutical Company Inc. Formulations nasales de calcitonine contenant du chlorobutanol

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2254061A1 (de) * 1972-11-04 1974-05-16 Hoechst Ag Lh-releasing hormon zur nasalen applikation
CA1098444A (fr) * 1975-05-26 1981-03-31 Leo Geller Preparations de peptide a action prolongee
GB1527605A (en) * 1975-08-20 1978-10-04 Takeda Chemical Industries Ltd Insulin preparation for intranasal administration
US4241051A (en) * 1977-11-04 1980-12-23 Christie Robert B Calcitonin
JPS56122309A (en) * 1980-03-03 1981-09-25 Teijin Ltd Calcitonin pharmaceutical for rectal administration
AU6596080A (en) * 1981-01-02 1981-06-25 Henkel Kgaa Treatment of disorders of calcium metabolism
JPS5989619A (ja) * 1982-10-05 1984-05-23 サンド・アクチエンゲゼルシヤフト カルシトニン組成物およびその用途
CH657779A5 (de) * 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.

Also Published As

Publication number Publication date
CA1222948A (fr) 1987-06-16
DK602783D0 (da) 1983-12-28
EP0115627B1 (fr) 1987-04-01
ZA839655B (en) 1984-08-29
ATE26215T1 (de) 1987-04-15
AU2259683A (en) 1984-07-05
PH20444A (en) 1987-01-09
IE833071L (en) 1984-06-29
AU572815B2 (en) 1988-05-19
IE56441B1 (en) 1991-07-31
NZ206728A (en) 1986-02-21
MX7547E (es) 1989-09-14
DE3370586D1 (en) 1987-05-07
IL70489A0 (en) 1984-03-30
EP0115627A1 (fr) 1984-08-15
JPS59130820A (ja) 1984-07-27

Similar Documents

Publication Publication Date Title
DK602783A (da) Farmaceutisk praeparat indeholdende calcitonin
HRP920667B1 (en) Application of fultripine active substance for preventing muscle deformation
SE8605515D0 (sv) A liquid dosage form for oral administration of a pharmaceutically active substance
DE3070189D1 (en) Medicament, particularly for the treatment of cholera, and pharmaceutical compositions containing it
IT1142135B (it) Polietilenimmina impiegata per l'assorbimento di sostanze alfattivamente attive
GB2146527B (en) Use of benzothiophene derivatives as antiasthmatic agents
IL77083A (en) Pharmaceutical compositions containing certain n-acyl-histidyl-prolinamide derivatives or salts thereof for the treatment of amyothropic lateral sclerosis and manufacture thereof
IL76561A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases
FR2618331B1 (fr) Compositions pharmaceutiques utiles pour le traitement de l'uremie
ES2054089T3 (es) Formulaciones orales liquidas.
IT8448983A1 (it) Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina
GB2008403A (en) Peptide Compositions
FR2522266B1 (fr) Procede de preparation d'un agent fibrinolytiquement actif et agent obtenu
IT1159815B (it) Composizione medicinale per il trattamento di certe neurovirosi
IL88737A (en) Aqueous pharmaceutical dithranol formulations for topical use
NO167381C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv (e)-2-(p-fluorfenethyl)-3-fluorallylamin.
PT76951B (en) Process for the preparation of racemic or optically active eburnane-oxime derivatives and pharmaceutical compositions containing them
IL71051A (en) Compositions containing active lipids for the treatment of cystic fibrosis
IT1171692B (it) Preparato farmaceutico impiegabile per il trattamento della lebbra e/o di altre micobatteriosi
IT8012005A0 (it) Apparecchio per la nebulizzazione di soluzioni medicamentose nelle inalazioni terapeutiche
IT1240853B (it) Composizione farmaceutica atta alla somministrazione intranasale comprendente calcitonina e una acil-carnitina

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment